Actionable news
All posts from Actionable news
Actionable news in FPRX: Five Prime Therapeutics, Inc.,

Five Prime Therapeutics posts 3Q loss

SOUTH SAN FRANCISCO, Calif. (AP) _ Five Prime Therapeutics Inc. (FPRX) on Monday reported a loss of $43.3 million in its third quarter.

The South San Francisco, California-based company said it had a loss of $1.54 per share.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.32 per share.

The biotech company that develops treatments targeting cancer and autoimmune diseases posted revenue of $8.3 million in the period.

Five Prime Therapeutics shares have declined 13 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $43.76, a drop of roughly 9 percent in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on FPRX at